三唑仑的临床评价

来源 :新药与临床 | 被引量 : 0次 | 上传用户:wori147258
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
三唑仑(triazolam)是一种苯二氮(艹卓)类催眠药,属精神药品。临床研究表明,本品可明显缩短入睡时间,增加睡眠时间,减少夜间觉醒次数。口服后迅速自胃肠道吸收,2h内达血药峰浓度,血浆T_(1/2)较短,范围为1.5—5.5h。本品自1978年上市后广泛用于失眠,尤适用于入睡困难的患者。目前我国亦有生产。1986年,澳大利亚药物评价委员会对本品的规格加以限制。本品最初上市 Triazolam is a benzodiazepine hypnotics, which is a psychotropic drug. Clinical studies have shown that this product can significantly reduce the time to fall asleep, increase sleep time and reduce the number of night awakenings. After oral administration absorbed rapidly from the gastrointestinal tract, within 2h of peak plasma concentration, plasma T_ (1/2) shorter, the range of 1.5-5.5h. This product is widely used for insomnia since it was launched in 1978, especially for patients who have difficulty falling asleep. At present, China also has production. In 1986, the Australian Drug Evaluation Committee to limit the specifications of the product. This product was first listed
其他文献